These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2178 related items for PubMed ID: 16818862

  • 21. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects.
    Bueller JA, Aftab M, Sen S, Gomez-Hassan D, Burmeister M, Zubieta JK.
    Biol Psychiatry; 2006 May 01; 59(9):812-5. PubMed ID: 16442082
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression.
    Montag C, Weber B, Fliessbach K, Elger C, Reuter M.
    Psychol Med; 2009 Nov 01; 39(11):1831-9. PubMed ID: 19335934
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Val66Met BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome.
    Cardoner N, Soria V, Gratacòs M, Hernández-Ribas R, Pujol J, López-Solà M, Deus J, Urretavizcaya M, Estivill X, Menchón JM, Soriano-Mas C.
    Depress Anxiety; 2013 Mar 01; 30(3):225-33. PubMed ID: 23165919
    [Abstract] [Full Text] [Related]

  • 27. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation.
    Szeszko PR, Lipsky R, Mentschel C, Robinson D, Gunduz-Bruce H, Sevy S, Ashtari M, Napolitano B, Bilder RM, Kane JM, Goldman D, Malhotra AK.
    Mol Psychiatry; 2005 Jul 01; 10(7):631-6. PubMed ID: 15768049
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Brain-derived neurotrophic factor Val66Met polymorphism and cognitive function in persons with cardiovascular disease.
    Szabo AJ, Alosco ML, Miller LA, McGeary JE, Poppas A, Cohen RA, Gunstad J.
    Psychogeriatrics; 2013 Dec 01; 13(4):206-12. PubMed ID: 24289461
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. ACE I/D polymorphism affects cognitive function and gray-matter volume in amnestic mild cognitive impairment.
    Zhang Z, Deng L, Bai F, Shi Y, Yu H, Yuan Y, Jiang T, Jia J, Zhang Z.
    Behav Brain Res; 2011 Mar 17; 218(1):114-20. PubMed ID: 21108975
    [Abstract] [Full Text] [Related]

  • 37. The association of genotypic combination of the DRD3 and BDNF polymorphisms on the adhesio interthalamica and medial temporal lobe structures.
    Takahashi T, Suzuki M, Tsunoda M, Kawamura Y, Takahashi N, Maeno N, Kawasaki Y, Zhou SY, Hagino H, Niu L, Tsuneki H, Kobayashi S, Sasaoka T, Seto H, Kurachi M, Ozaki N.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul 01; 32(5):1236-42. PubMed ID: 18472202
    [Abstract] [Full Text] [Related]

  • 38. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease.
    Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington KD, Bourgeat P, Salvado O, Darby D, Snyder PJ, Bush AI, Martins RN, Masters CL, Rowe CC, Nathan PJ, Maruff P, Australian Imaging, Biomarkers and Lifestyle (AIBL) Research Group.
    Neurobiol Aging; 2013 Nov 01; 34(11):2457-64. PubMed ID: 23769397
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 109.